Overview

ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

Status:
Recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
ML-004-003 is a multi-center, open-label extension study that will enroll approximately 120 adolescent and adult subjects with ASD that have completed study ML-004-002.
Phase:
Phase 2
Details
Lead Sponsor:
MapLight Therapeutics